Publication | Closed Access
Engineering Single-Atom Iron Nanozymes with Radiation-Enhanced Self-Cascade Catalysis and Self-Supplied H<sub>2</sub>O<sub>2</sub> for Radio-enzymatic Therapy
114
Citations
70
References
2022
Year
Single-atom nanozymes (SAzymes), with individually isolated metal atom as active sites, have shown tremendous potential as enzyme-based drugs for enzymatic therapy. However, using SAzymes in tumor theranostics remains challenging because of deficient enzymatic activity and insufficient endogenous H<sub>2</sub>O<sub>2</sub>. We develop an external-field-enhanced catalysis by an atom-level engineered FeN<sub>4</sub>-centered nanozyme (FeN<sub>4</sub>-SAzyme) for radio-enzymatic therapy. This FeN<sub>4</sub>-SAzyme exhibits peroxidase-like activity capable of catalyzing H<sub>2</sub>O<sub>2</sub> into hydroxyl radicals and converting single-site Fe<sup>II</sup> species to Fe<sup>III</sup> for subsequent glutathione oxidase-like activity. Density functional theory calculations are used to rationalize the origin of the single-site self-cascade enzymatic activity. Importantly, using X-rays can improve the overall single-site cascade enzymatic reaction process via promoting the conversion frequency of Fe<sup>II</sup>/Fe<sup>III</sup>. As a H<sub>2</sub>O<sub>2</sub> producer, natural glucose oxidase is further decorated onto the surface of FeN<sub>4</sub>-SAzyme to yield the final construct GOD@FeN<sub>4</sub>-SAzyme. The resulting GOD@FeN<sub>4</sub>-SAzyme not only supplies in situ H<sub>2</sub>O<sub>2</sub> to continuously produce highly toxic hydroxyl radicals but also induces the localized deposition of radiation dose, subsequently inducing intensive apoptosis and ferroptosis in vitro. Such a synergistic effect of radiotherapy and self-cascade enzymatic therapy allows for improved tumor growth inhibition with minimal side effects in vivo. Collectively, this work demonstrates the introduction of external fields to enhance enzyme-like performance of nanozymes without changing their properties and highlights a robust therapeutic capable of self-supplying H<sub>2</sub>O<sub>2</sub> and amplifying self-cascade reactions to address the limitations of enzymatic treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1